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| INTRODUC TI ON
Chronic obstructive pulmonary disease (COPD) is a common chronic inflammatory disease impairing lung function. Lower respiratory microbial colonization often occurs during stable stage of this disease, of whom Pseudomonas aeruginosa (P aeruginosa) is the main colony. 1 Unlike bacteria infecting body in an acute way, P aeruginosa colonizing in the body usually cannot be easily killed and cleaned by bactericidal/permeability-increasing (BPI) protein-a kind of protein presented by neutrophil (NEU), 2 and on the contrary, it contributes to the production of autoantibody against BPI, unable it to clean pathogenic microorganism and inducing inflammatory responses. 3 The current study was retrospectively designed to evaluate pulmonary disease severity of COPD patients with P aeruginosa chronic colonization, via comparing the lung function and serum tumor necrosis factor (TNF)-α, interleukin(IL)-6 and IL-1β, and C-reactive protein (CRP) levels between patients seropositive for BPI-ANCA and those seronegative to explore the association of BPI-ANCA with patient's lung inflammation levels and explore the clinical significance of serum BPI-ANCA detection in COPD combined with P aeruginosa colonization.
| MATERIAL S AND ME THODS

| Participants
We continuously collected 2053 outpatient and inpatient pa- those suffering from surgery, severe stress, neuropsychiatric disorders that cannot cooperate to complete pulmonary function test because of any causes, and patients diagnosed with other lung diseases except for COPD including bronchiectasis, interstitial lung disease, asthma, tuberculosis, lung cancer, and sleep apnea syndrome were excluded from this study. Details of patients' inclusion and exclusion criteria are shown in Figure 1 . COPD patients with P aeruginosa isolated from sputum culture, in whose course of 6 months, P aeruginosa was isolated in three or more consecutive sputum culture for at least 1 month, were considered to be P aeruginosa chronic colonization 5 (P aeruginosa colonization group), and P aeruginosa infection (P aeruginosa infection group) otherwise. 
| Measurement of lung function
Pulmonary function tests were performed using a German-born 
| Statistical analysis
The analysis was performed using SPSS 23.0 software. The normality and variance homogeneity of the measurement data were analyzed by 
| RE SULTS
| Characteristics and anthropometrics of participants
Positive rate of BPI-ANCA was 48.15% in 216 COPD patients with P aeruginosa colonization, highest compared to those with P aeruginosa infection and healthy controls, and perinuclear antineutrophil cytoplasmatic antibodies (p-ANCA) and cytoplasmic antineutrophil cytoplasmic antibodies (c-ANCA) were negative (not listed in the results). And illness duration and numbers of patients admitted to hospital within 6 months before enrollment was also significant between groups. Differences in general information such as age, gender, and smoke exposure among groups were not statistically significant. See details in Table 1 . 
| Anthropometric comparison between COPD
ANCA and negative
In Table 3 , serum levels of inflammatory markers (including TNF-α, IL-6, IL-1β, and CRP) and NEU% of COPD patients combined with P aeruginosa colonization were compared. TNF-α, IL-6, IL-1β, CRP, and NEU% levels in the BPI-ANCA(+) group were all higher than that in the BPI-ANCA (−) group, as shown in Table 3 . 
| Association of FEV
TA B L E 2 Comparison of general data
between patients with BPI-ANCA(+) and BPI-ANCA(-) of patients with COPD combined with Pseudomonas aeruginosa colonization (−) group is shown in Table 5 . The number of patients with very severe airflow limitation in the BPI-ANCA(+) group (n = 104) was significantly higher than that in the BPI-ANCA(−) group [38 (36.54%) vs 22 (19.64%)], and the difference was statistically significant (P = 0.018).
Serum TNF-α (65.73 ± 14.45 pg/mL), IL-6 (54.18 ± 11.88 pg/mL), and IL-1β (3.97 ± 1.08 pg/mL) levels in patients with very severe airflow limitation were significantly higher than those in the mild, moderate, and severe groups (P < 0.001).
| D ISCUSS I ON
Chronic obstructive pulmonary disease is a kind of obstructive lung disease characterized by long-term and chronic breathing problems and airflow limitation and usually gets worse over time. Tobacco smoking, air pollution, and occupation exposure are primary causes of chronic inflammation. 7 P aeruginosa is a common opportunist, colonizing in the body for long time without inflammatory responses while causing serious infection during existing disease-for example, COPD. 8 As a chronic disease, COPD is, P aeruginosa colonizing in patients usually have enough time to form a biofilm, which helps it escape from body immune system, ensuring its long-term colonization and even probably resulting in patients' acute exacerbation of COPD(AECOPD) during certain condition. Results of the current study showed that illness duration of P aeruginosa colonization group was longer (12.32 ± 5.23 vs 10.77 ± 4.95 year) and more patients in P aeruginosa colonization group admitted to hospital within 6 months before enrollment. As mentioned before, chronic disease characteristic of COPD was one of the requirements for P aeruginosa to form biofilm and against being cleaned, so it is reasonable that there is significant difference in illness duration between groups. And serum BPI-ANCA positivity in the P aeruginosa colonization group (48.15%) was higher than patients with P aeruginosa infection (2.46%) in the present study.
However, positive rate of BPI-ANCA here was lower compared to what reported by Lachenal et al, 14 which might cause by different sample size, illness duration and subtypes of P aeruginosa. What's more, in the current study we detected IgG-BPI-ANCA only, considering that it is the main type of autoantibody against BPI.
Thomsen et al 15 reported that COPD patients with elevated levels of CRP and NEU count usually had higher risk of AECOPD, even those with relative moderate symptoms. The present study detected TNF-α, IL-6, IL-1β, CRP, and NEU% levels in COPD patients with P aeruginosa colonization and found that inflammatory markers were higher in patients seropositive for BPI-ANCA than those negative, indicating a link between BPI-ANCA positivity and inflammatory status in COPD patients with P aeruginosa colonization. A 10-year study followed 46 patients with cystic fibrosis and P aeruginosa colonization drawn conclusion basically consistent with us-it showed that 15/28 BPI-ANCA(+) patients developed adverse outcomes TA B L E 3 Serum inflammatory markers were compared between the two groups 
17
Cytokines act as the main inflammatory mediator to regulate the aggregation and activation of inflammatory cells, which will release more proteases or oxidants to further aggravate the damage of airway epithelium and lung tissue. Previous research has showed that TNF-α was involved in the process of NEU activation during airway inflammation, resulting in a large amount of NEU infiltrating in the airway mucosa and enhancing the solubility of extracellular elastin, which is responsible for airway restructure, 18 while both IL-6 and IL-1β played regulatory role in immune responses and participated in disease development and tissue damage. 19 Zhou et al 20 reported
that serum IL-1β in COPD patients was significantly elevated com- cytokine levels were susceptible to multiple factors, for example, IL-6 levels were seriously affected by nutritional status and its levels usually elevated in patients with lower BMI or dystrophy. 22 We, in the current study, selected COPD patients with P aeruginosa colonization in a relatively stable illness stage and excluded those with chronic consumptions such as heart failure, diabetes mellitus, and malignant neoplasm and those with dystrophia to minimize the influence of confounding factors.
A total of 216 patients studied currently were grouped according to severity of COPD airflow limitation based on the GOLD criteria.
Results showed that the proportion of patients with very severe airway limitation in BPI-ANCA(+) patients were 36.54%, higher than that in the BPI-ANCA(−) group, and inflammatory indicator levels in patients with very severe airflow limitation were higher compared to other groups, suggesting that inflammation levels of COPD patients with P aeruginosa colonization and seropositive for BPI-ANCA might be higher compared to those seronegative and should be paid more attention during disease management.
In conclusion, our study suggests that BPI-ANCA positivity is associated with inflammatory status in COPD patients with pulmonary P aeruginosa colonization and can be used as a potential biomarker assisting physicians in disease management.
CO N FLI C T O F I NTE R E S T S
All authors declared that they have no conflict of interests. TA B L E 5 Serum levels of TNF-α, IL-6, and IL-1β at different levels of COPD airflow limitation
O RCI D
Yongjian
